Mercados españoles abiertos en 5 hrs 37 min

Abbott Laboratories (ABT)

NYSE - NYSE Precio demorado. Divisa en USD
Añadir a la lista de favoritos
109,11-1,79 (-1,61%)
Al cierre: 04:00PM EDT
108,99 -0,12 (-0,11%)
Después del cierre: 07:59PM EDT

Abbott Laboratories

100 Abbott Park Road
Abbott Park
North Chicago, IL 60064-6400
United States
224 667 6100
https://www.abbott.com

Sector(es)Healthcare
SectorMedical Devices
Empleados a tiempo completo114.000

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Robert B. FordChairman of the Board, President & CEO4,73M6,64M1974
Mr. Philip P. BoudreauCFO & Senior VP of Finance1,14MN/A1973
Mr. Hubert L. AllenExecutive VP, General Counsel & Secretary2MN/A1966
Mr. Robert E. Funck Jr.Executive Vice President of Finance2,18MN/A1961
Mr. Daniel Gesua Sive SalvadoriExecutive VP and Group President of Established Pharmaceuticals & Nutritional Products1,76MN/A1979
Ms. Lisa D. EarnhardtExecutive VP & Group President of Medical Devices1,73MN/A1970
Ms. Sabina EwingSenior VP of Business & Technology Services and Chief Information OfficerN/AN/A1974
Erica L. BattagliaVP and Chief Ethics & Compliance OfficerN/AN/AN/A
Ms. Melissa BrotzVice President of Public Affairs & Corporate MarketingN/AN/AN/A
Mr. Christopher J. ScogginsSenior Vice President of Commercial Operations, Marketing & Diabetes CareN/AN/A1970
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Gobierno corporativo

El ISS Governance QualityScore de Abbott Laboratories, a día 1 de abril de 2024, es 6. Las puntuaciones base son Auditoría: 8; Tablero: 5; Derechos de los accionistas: 2; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.